Invention Application
WO2017083592A1 ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA
审中-公开
为白血病患者选择治疗方案的测定和方法
- Patent Title: ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA
- Patent Title (中): 为白血病患者选择治疗方案的测定和方法
-
Application No.: PCT/US2016/061444Application Date: 2016-11-10
-
Publication No.: WO2017083592A1Publication Date: 2017-05-18
- Inventor: GORDON, Max , TARDI, Paul , TYNER, Jeffrey , MAYER, Lawrence
- Applicant: CELATOR PHARMACEUTICALS, INC. , OREGON HEALTH & SCIENCES UNIVERSITY
- Applicant Address: 200 PrincetonSouth Corporate Center, Suite 180 Ewing, NJ 08628 US
- Assignee: CELATOR PHARMACEUTICALS, INC.,OREGON HEALTH & SCIENCES UNIVERSITY
- Current Assignee: CELATOR PHARMACEUTICALS, INC.,OREGON HEALTH & SCIENCES UNIVERSITY
- Current Assignee Address: 200 PrincetonSouth Corporate Center, Suite 180 Ewing, NJ 08628 US
- Agency: MURASHIGE, Kate, H. et al.
- Priority: US62/254,109 20151111
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61P35/00 ; A61P35/02 ; C12Q1/68
Abstract:
Diagnostic methods for identifying cancer bearing subjects appropriate for treatment with CPX-351 include genetic and ex vivo testing of cells from a candidate subject. Combination treatment with CPX-351 and FLT-3 inhibitors improve CPX-351 uptake and toxicity.
Information query
